The TET2 mRNA levels in hypermethylated AML samples displayed a marginal decrease compared with those in nonhypermethylated AML samples (0.053, 0.012–0.25 vs 0.087, 0.012–0.469; P = 0.068) (Fig. 2). Here, TET2 is linked to acute myeloid leukemia.